AEZS-108

DRUG3 trials

Sponsors

AEterna Zentaris

Conditions

Breast CancerEndometrial CancerOvarian CancerUrothelial Carcinoma

Phase 1

A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy

TerminatedNCT01234519

AEterna ZentarisUrothelial Carcinoma

Start: 2010-11-30End: 2014-11-30Updated: 2018-03-15

Phase 2

Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors

CompletedNCT00569257

AEterna ZentarisEndometrial Cancer, Ovarian Cancer

Start: 2007-12-31End: 2011-07-31Updated: 2011-12-13

Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer

TerminatedNCT01698281

AEterna ZentarisBreast Cancer

Start: 2012-12-31End: 2014-10-31Updated: 2018-02-22

Related Papers

Phase 1 trial of zoptarelin doxorubicin (Zop-Dox) in advanced unresectable or metastatic urothelial carcinoma (UC) patients who failed platinum-based chemotherapy.

Journal of Clinical Oncology2014-05-20